(Q53384670)

13 May 2018

title

Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states. (English)

1 reference

13 May 2018

1 reference

Melissa M Brown

1

1 reference

13 May 2018

Gary C Brown

series ordinal

2

1 reference

13 May 2018

Sanjay Sharma

series ordinal

3

1 reference

13 May 2018

Brandon Busbee

series ordinal

4

1 reference

13 May 2018

publication date

1 June 2003

1 reference

13 May 2018

published in

Ophthalmology

1 reference

13 May 2018

volume

110

1 reference

13 May 2018

issue

6

1 reference

13 May 2018

page(s)

1076-1081

1 reference

13 May 2018

Multicenter trial of cryotherapy for retinopathy of prematurity. Snellen visual acuity and structural outcome at 5 1/2 years after randomization

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Photocoagulation for Diabetic Macular Edema

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Outcome of corneal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Utility values associated with blindness in an adult population

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Cost-effectiveness of treatment for threshold retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Incremental cost effectiveness of laser photocoagulation for subfoveal choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

The cost-effectiveness of grid laser photocoagulation for the treatment of diabetic macular edema: results of a patient-based cost-utility analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Utility values and diabetic retinopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Utility values and age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Quality of life and systemic comorbidities in patients with ophthalmic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Subjective and objective assessments of medical comorbidity in chronic depression

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Patients' perceptions--a shift in medical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Adding insult to injury. Usurping patients' prerogatives

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Patients' preferences in randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Incorporating patients' preferences into medical decisions

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

One thousand health-related quality-of-life estimates

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Symptom severity and patients' values in the decision to perform a transurethral resection of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Patients' utilities for cancer treatments: a study of the chained procedure for the standard gamble and time tradeoff.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Utility assessment in cancer patients: adjustment of time tradeoff scores for the utility of life years and comparison with standard gamble scores.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Quality of life associated with diabetes mellitus in an adult population.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Health values of patients infected with human immunodeficiency virus. Relationship to mental health and physical functioning

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Defining post-stroke recovery: implications for design and interpretation of drug trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Cost-utility analysis of paclitaxel in combination with cisplatin for patients with advanced ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Iliac arterial occlusive disease: cost-effectiveness analysis of stent placement versus percutaneous transluminal angioplasty. Dutch Iliac Stent Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

The effect of elective total hip replacement on health-related quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

A study of the quality of life and cost-utility of renal transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

The utility of different health states as perceived by the general public

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Quality of life of patients with ulcerative colitis preoperatively and postoperatively

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Parameter estimates for a QALY utility model

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Utility approach to measuring health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

The VF-14 index of functional visual impairment in candidates for a corneal graft

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

Managing pharmaceutical expenditure while increasing access. The pharmaceutical management agency (PHARMAC) experience

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900254-9

7 January 2021

10.1016/S0161-6420(03)00254-9

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018